#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study Comparing Ipilimumab and Nivolumab to Nivolumab Alone for Patients with Resectable Stage III Melanoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study of Regorafenib with BRAF/MEK-Inhibitor Combination for Patients with Advanced Melanoma After Previous Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

  • Study of LTX-315 and Pembrolizumab for Patients with Resectable Stage III-IV Melanoma

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway

  • Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • A study of ipilimumab and nivolumab to observe immune system changes in patients with unresectable stage III or IV melanoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of BNT111 and cemiplimab in patients with advanced melanoma who have not responded to other therapies

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Poland Spain

  • Study of local treatment options for large metastases in patients with BRAF V600 mutated melanoma receiving Encorafenib and Binimetinib combination therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on L19IL2 and L19TNF Treatment Before Surgery for Patients with Advanced Melanoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland

  • Study on the Safety of Continued Treatment with GME751 (Pembrolizumab Biosimilar) for Patients with Melanoma or Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Lithuania Romania Spain

  • Study of Nivolumab and Relatlimab for Patients with Stage III-IV Melanoma After Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +7